Patient-led pharmaceutical research
Funded by epileptics, led by epileptics, benefitting epileptics. We build the tools that make epilepsy care proactive, personalised, and safe.
From wearable biomarkers to compliance-grade operations, Medora ships the full technological stack for modern epileptology.
Our Mission
50 million people worldwide live with epilepsy. For most, seizures are unpredictable — and that unpredictability defines their entire life: where they can go, what they can do, whether they can drive, work, or sleep without fear.
We are epileptics building the infrastructure to change that — a seizure detector, a health tracker, and the community to fund and guide both. Patient-led. Patient-funded. Built for the people who need it most.
01
A non-invasive wearable that gives patients 5–10 minutes of warning — enough time to reach safety.
02
A health tracker that turns daily logs into patterns — giving patients and doctors real data, not guesses.
03
Our software products generate the revenue that funds our medical R&D. Every demo booked advances the mission.
